You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Mutation in novel coronavirus may have made it more contagious: Study

The novel coronavirus is accumulating genetic mutations, one of which may have made it more contagious, according to a study involving more than 5,000 Covid-19 patients in the US

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  Houston 

coronavirus
A health official collects a swab sample to test for Covid-19

The novel is accumulating genetic mutations, one of which may have made it more contagious, according to a study involving more than 5,000 COVID-19 patients in the US.

The research, published in the journal mBIO, however, did not find that these mutations have made the virus deadlier or changed clinical outcomes.

The researchers noted that the mutation, called D614G, is located in the spike protein that pries open our cells for viral entry.

"The virus is mutating due to a combination of neutral drift -- which just means random genetic changes that don't help or hurt the virus -- and pressure from our immune systems," said Ilya Finkelstein, associate professor at The University of Texas at Austin, US.

The researchers noted that during the initial wave of the pandemic, 71 per cent of the novel coronaviruses identified in patients in Houston had this mutation.

When the second wave of the outbreak hit Houston during the summer, this variant had leaped to 99.9 per cent prevalence, they said.

This mirrors a trend observed around the world, according to the researchers.

The reason why strains containing this mutation outcompete those that didn't have it may be that natural selection would favour strains of the virus that transmit more easily, the researchers said.

However, some scientists have suggested another explanation, called "founder's effects."

In that scenario, the D614G mutation might have been more common in the first viruses to arrive in Europe and North America, essentially giving them a head start on other strains, according to the researchers.

The spike protein is also continuing to accumulate additional mutations of unknown significance, they said.

The team also showed in lab experiments that at least one such mutation allows spike to evade a neutralising antibody that humans naturally produce to fight SARS-CoV-2 infections.

The researchers said this may allow that variant of the virus to more easily slip past our immune systems.

Although it is not clear yet whether that translates into it also being more easily transmitted between individuals, they said.

The scientists noted a total of 285 mutations across thousands of infections, although most don't appear to have a significant effect on how severe the disease is.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, November 02 2020. 12:12 IST
RECOMMENDED FOR YOU